Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Integrity of the anterior visual pathway and its association with ambulatory performance in multiple sclerosis.
The plasticity of human Treg and Th17 cells and its role in autoimmunity.
Using EAE to better understand principles of immune function and autoimmune pathology.
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK.
Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice.
Natalizumab-Induced Progressive Multifocal Leukoencephalopathy.
Health status, work impediments, and coping related to work roles of women with multiple sclerosis.
Burden of disease of multiple sclerosis in Korea.
Magnetic resonance imaging of blood brain/nerve barrier dysfunction and leukocyte infiltration: closely related or discordant?
[Natalizumab in the treatment of patients with relapsing-remitting multiple sclerosis: the preliminary results of the observational program "Sovet"]
Immune-mediated inflammatory diseases: progress in molecular pathogenesis and therapeutic strategies.
AMP-Activated Protein Kinase Signaling Protects Oligodendrocytes that Restore Central Nervous System Functions in an Experimental Autoimmune Encephalomyelitis Model.
Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.
An online programme to reduce depression in patients with multiple sclerosis: a randomised controlled trial.
The zebrafish as a gerontology model in nervous system aging, disease, and repair.
Facial hypersensitivity and trigeminal pathology in mice with experimental autoimmune encephalomyelitis (EAE).
Natural killer cells and their receptors in multiple sclerosis.
Role of Formyl Peptide Receptors (FPR) in Abnormal Inflammation Responses Involved in Neurodegenerative Diseases.
Management of fatigue in persons with multiple sclerosis.
Relapses and disability accumulation in progressive multiple sclerosis.
[Two new oral disease modifying therapies in relapsing remitting multiple sclerosis].
Articulation time does not affect speeded cognitive performance in multiple sclerosis.
Longitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosis.
Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci.
Insights into multiple sclerosis provided by non-coding RNAs: meeting summary from the symposium 'Non-coding RNAs in autoimmune disorders of the central nervous system' on 5 April 2013 in Warsaw, Poland.
Pages
« first
‹ previous
…
431
432
433
434
435
436
437
438
439
…
next ›
last »